The AI workspace for legal professionals
- Legal research with access to more than 1 million sources
- Document automation
- Matter management
- Hosted in the EU and Switzerland
Try it free for 14 days (10 questions/day during trial)
The AI workspace for legal professionals
Try it free for 14 days (10 questions/day during trial)
24-1149•Teva Pharmaceuticals International Gmbh, Teva Pharmaceuticals USA, Inc. v. Eli Lilly and Company
24-1149Court of Appeals for the Federal CircuitSep 8, 2025
N OTE: This order is nonprecedential.
United States Court of Appeals
for the Federal Circuit
______________________
TEVA PHARMACEUTICALS INTERNATIONAL
GMBH, TEVA PHARMACEUTICALS USA, INC.,
Appellants
v.
ELI LILLY AND COMPANY,
Appellee
______________________
2024-1094
______________________
Appeal from the United States District Court for the
District of Massachusetts in No. 1:18-cv-12029-ADB, Judge
Allison Dale Burroughs.
-------------------------------------------
TEVA PHARMACEUTICALS INTERNATIONAL
GMBH, TEVA PHARMACEUTICALS USA, INC.,
Plaintiffs-Appellees
v.
ELI LILLY AND COMPANY,
Defendant- Appellant
______________________
2024-1149
______________________
-- 1 of 2 --
TEVA PHARMACEUTICALS INTERNATIONAL GMBH v.
ELI LILLY AND COMPANY
2
Appeal from the United States District Court for the
District of Massachusetts in No. 1:18-cv-12029-ADB, Judge
Allison Dale Burroughs.
______________________
O R D E R
Teva Pharmaceuticals International GmbH, Teva Phar-
maceuticals USA, Inc, and Eli Lilly and Company stipulate
to voluntary dismiss Appeal No. 24-1149.
The parties, having so agreed,
I T I S O RDERED T HAT :
(1) Appeal No. 24-1149 is dismissed under Fed. R.
App. P. 42(b), with each side to bear their own costs.
(2) The official captions as modified, are reflected in
this order.
September 8, 2025
Date
F OR THE COURT
ISSUED AS A MANDATE (as to Appeal No. 24-1149
only): September 8, 2025.
-- 2 of 2 --
Connect Omnilex to search the legal corpus from your AI assistant.